Abstract
Target-mediated drug disposition (TMDD) is a phenomenon characterized by a drug’s high-affinity binding to a target molecule, which significantly influences its pharmacokinetic profile within an organism. The comprehensive TMDD model delineates this interaction, yet it may become overly complex and computationally demanding in the absence of specific concentration data for the target or its complexes. Consequently, simplified TMDD models employing quasi-steady state approximations (QSSAs) have been introduced; however, the precise conditions under which these models yield accurate results require further elucidation. Here, we establish the validity of three simplified TMDD models: the Michaelis-Menten model reduced with the standard QSSA (mTMDD), the QSS model reduced with the total QSSA (qTMDD), and a first-order approximation of the total QSSA (pTMDD). Specifically, we find that mTMDD is applicable only when initial drug concentrations substantially exceed total target concentrations, while qTMDD can be used for all drug concentrations. Notably, pTMDD offers a simpler and faster alternative to qTMDD, with broader applicability than mTMDD. These findings are confirmed with antibody-drug conjugate real-world data. Our findings provide a framework for selecting appropriate simplified TMDD models while ensuring accuracy, potentially enhancing drug development and facilitating safer, more personalized treatments.
Funder
National Research foundation of Korea
National Research Foundation of Korea
Institute for Basic Science
Publisher
Public Library of Science (PLoS)
Reference34 articles.
1. Pharmacologic target-mediated drug disposition;G. Levy;Clinical Pharmacology & Therapeutics,1994
2. Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies.;M Dostalek;Clinical Pharmacokinetics.,2013
3. General pharmacokinetic model for drugs exhibiting target-mediated drug disposition;DE Mager;Journal of pharmacokinetics and pharmacodynamics,2001
4. The pharmacokinetics and pharmacodynamics of monoclonal antibodies-mechanistic modeling applied to drug development;DR Mould;Current Opinion in Drug Discovery and Development,2007
5. A model-based approach to predicting the human pharmacokinetics of a monoclonal antibody exhibiting target-mediated drug disposition;KT Luu;Journal of Pharmacology and Experimental Therapeutics,2012
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献